India's Serum institute to sell AstraZeneca vaccine to private hospitals at $8/dose


  • World
  • Wednesday, 21 Apr 2021

FILE PHOTO: Officials unload boxes containing vials of AstraZeneca's COVISHIELD, a coronavirus disease (COVID-19) vaccine manufactured by Serum Institute of India, outside a vaccination storage centre in Ahmedabad, India, January 12, 2021. REUTERS/Amit Dave

NEW DELHI (Reuters) - The Serum Institute of India said on Wednesday it would sell the AstraZeneca vaccine to the country's state governments at 400 rupees ($5.30) per dose and to private hospitals at 600 rupees ($7.95).

"Furthermore, owing to the complexity, and urgency of the situation it is challenging to supply it independently to each corporate entity," it said in a statement. "We would urge all corporate and private individuals to access the vaccines through the state facilitated machinery and private health systems."

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

Teenager charged with terrorism over Sydney bishop stabbing
UK PM Sunak to consult on tougher rules to combat 'sick note culture'
Weekly storage of natural gas in U.S. increases: EIA
U.S. stocks end mixed, S&P 500 down for 5th day
Canada to host UN event for global solution to end plastic pollution
U.S. stocks close mixed
India votes in gigantic election as Modi seeks historic third term
Crude futures settle mixed
Bosch Group to harness climate action for future growth
U.S. dollar ticks up

Others Also Read